{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:46:10Z","timestamp":1767465970657,"version":"3.48.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"DOI":"10.7759\/cureus.100702","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:42:25Z","timestamp":1767465745000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Peptic Ulcer Disease and Gastrointestinal Hemorrhage With Long-Term Use of Antiplatelet and Anticoagulant Therapy in Patients With Ischemic Heart Disease"],"prefix":"10.7759","author":[{"given":"Kanav","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha Shahid","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mian Mubeen","family":"Mansha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil Charles","family":"Madathiparambu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliha","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Younas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali Zaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.05.031","article-title":"Association of antisecretory drugs with upper gastrointestinal bleeding in patients using oral anticoagulants: a systematic review and meta-analysis","volume":"135","author":"Kurlander JE","year":"2022","unstructured":"Kurlander JE, Barnes GD, Fisher A, et al.. Association of antisecretory drugs with upper gastrointestinal bleeding in patients using oral anticoagulants: a systematic review and meta-analysis. Am J Med. 2022, 135:1231-43.e8. 10.1016\/j.amjmed.2022.05.031","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v4.i1.40","article-title":"Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy","volume":"4","author":"Yasuda H","year":"2015","unstructured":"Yasuda H, Matsuo Y, Sato Y, et al.. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med. 2015, 4:40-6. 10.5492\/wjccm.v4.i1.40","journal-title":"World J Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.29261\/pakvetj\/2024.210","article-title":"Evaluating the impact of trimetadizine on myocardial ischemia-reperfusion injury through mitochondrial ATP pathway in rats","volume":"44","author":"Wang X","year":"2024","unstructured":"Wang X, Xu Z, Zhuang Y, Guo X, Hu K, Su G. Evaluating the impact of trimetadizine on myocardial ischemia-reperfusion injury through mitochondrial ATP pathway in rats. Pak Vet J. 2024, 44:715-20. 10.29261\/pakvetj\/2024.210","journal-title":"Pak Vet J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"54","author":"Kushner FG","year":"2009","unstructured":"Kushner FG, Hand M, Smith SC Jr, et al.. 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009, 54:2205-41. 10.1016\/j.jacc.2009.10.015","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996, 348:1329-39. 10.1016\/S0140-6736(96)09457-3","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/09537100500237004","article-title":"Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and\/or clopidogrel: where we are now?","volume":"17","author":"Liberopoulos EN","year":"2006","unstructured":"Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and\/or clopidogrel: where we are now?. Platelets. 2006, 17:1-6. 10.1080\/09537100500237004","journal-title":"Platelets"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2017.11.001","article-title":"Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and\u00a0pulmonary embolism","volume":"98","author":"Jacobs B","year":"2018","unstructured":"Jacobs B, Henke PK. Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and\u00a0pulmonary embolism. Surg Clin North Am. 2018, 98:239-53. 10.1016\/j.suc.2017.11.001","journal-title":"Surg Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004517","article-title":"Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients","volume":"6","author":"Lamberts M","year":"2017","unstructured":"Lamberts M, Staerk L, Olesen JB, et al.. Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients. J Am Heart Assoc. 2017, 6:004517. 10.1161\/JAHA.116.004517","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"Garc\u00eda Rodr\u00edguez LA","year":"2011","unstructured":"Garc\u00eda Rodr\u00edguez LA, Lin KJ, Hern\u00e1ndez-D\u00edaz S, Johansson S. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation. 2011, 123:1108-15. 10.1161\/CIRCULATIONAHA.110.973008","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4606","article-title":"Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores","volume":"349","author":"Hippisley-Cox J","year":"2014","unstructured":"Hippisley-Cox J, Coupland C. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ. 2014, 349:g4606. 10.1136\/bmj.g4606","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30037-2","article-title":"Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials","volume":"3","author":"Scally B","year":"2018","unstructured":"Scally B, Emberson JR, Spata E, et al.. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. Lancet Gastroenterol Hepatol. 2018, 3:231-41. 10.1016\/S2468-1253(18)30037-2","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32404-7","article-title":"Peptic ulcer disease","volume":"390","author":"Lanas A","year":"2017","unstructured":"Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017, 390:613-24. 10.1016\/S0140-6736(16)32404-7","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0150","article-title":"Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies","volume":"110","author":"Desai J","year":"2013","unstructured":"Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies. Thromb Haemost. 2013, 110:205-12. 10.1160\/TH13-02-0150","journal-title":"Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.02.014","article-title":"Gastrointestinal surgery and endoscopy: recent trends in competition and collaboration","volume":"15","author":"Baffy G","year":"2017","unstructured":"Baffy G, Fisichella PM. Gastrointestinal surgery and endoscopy: recent trends in competition and collaboration. Clin Gastroenterol Hepatol. 2017, 15:799-803. 10.1016\/j.cgh.2017.02.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37890","article-title":"Aspirin vs clopidogrel: antiplatelet agent of choice for those with recent bleeding or at risk for gastrointestinal bleed","volume":"15","author":"Gosavi S","year":"2023","unstructured":"Gosavi S, Krishnan G, Acharya RV. Aspirin vs clopidogrel: antiplatelet agent of choice for those with recent bleeding or at risk for gastrointestinal bleed. Cureus. 2023, 15:e37890. 10.7759\/cureus.37890","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000151","article-title":"Combining antiplatelet and anticoagulant therapy in cardiovascular disease","volume":"2020","author":"Barnes GD","year":"2020","unstructured":"Barnes GD. Combining antiplatelet and anticoagulant therapy in cardiovascular disease. Hematology Am Soc Hematol Educ Program. 2020, 2020:642-8. 10.1182\/hematology.2020000151","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000377","article-title":"Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines","volume":"94","author":"Gutermann IK","year":"2015","unstructured":"Gutermann IK, Niggemeier V, Zimmerli LU, Holzer BM, Battegay E, Scharl M. Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines. Medicine. 2015, 94:e377. 10.1097\/MD.0000000000000377","journal-title":"Medicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422316-association-of-peptic-ulcer-disease-and-gastrointestinal-hemorrhage-with-long-term-use-of-antiplatelet-and-anticoagulant-therapy-in-patients-with-ischemic-heart-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:42:26Z","timestamp":1767465746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422316-association-of-peptic-ulcer-disease-and-gastrointestinal-hemorrhage-with-long-term-use-of-antiplatelet-and-anticoagulant-therapy-in-patients-with-ischemic-heart-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.100702","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,3]]}}}